Salud financiera de hoja de balance de Research Solutions

Salud financiera controles de criterios 5/6

Research Solutions tiene un patrimonio de los accionistas total de $14.0M y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $39.5M y $25.5M respectivamente.

Información clave

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	US$4.22m
Patrimonio	US$14.13m
Total pasivo	US$26.67m
Activos totales	US$40.80m

Actualizaciones recientes sobre salud financiera

We're Not Worried About Research Solutions' (NASDAQ:RSSS) Cash Burn

Dec 16

Companies Like Research Solutions (NASDAQ:RSSS) Can Afford To Invest In Growth

Jun 14

Recent updates

Take Care Before Diving Into The Deep End On Research Solutions, Inc. (NASDAQ:RSSS)

Mar 14

Artko Capital - Research Solutions: A Tumultuous Year But Outlook And Growth Look Excellent

Mar 07

Research Solutions, Inc. (NASDAQ:RSSS) Shares Could Be 46% Below Their Intrinsic Value Estimate

Sep 18

The Research Solutions (NASDAQ:RSSS) Share Price Is Up 402% And Shareholders Are Delighted

Feb 12

Our View On Research Solutions' (NASDAQ:RSSS) CEO Pay

Dec 21

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($11.6M) de RSSS no cubren sus pasivos a corto plazo ($16.7M).

Pasivo a largo plazo: Los activos a corto plazo de RSSS ($11.6M) superan a sus pasivos a largo plazo ($8.8M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: RSSS está libre de deudas.

Reducción de la deuda: RSSS no tenía deudas hace 5 años.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: Aunque no es rentable RSSS tiene suficiente cash runway para más de 3 años si mantiene su actual nivel positivo de flujo de caja libre.

Pronóstico de cash runway: RSSS no es rentable pero tiene suficiente cash runway para más de 3 años, debido a que el flujo de caja libre es positivo y crece un 22.3% al año.

Salud financiera de hoja de balance de Research Solutions

Salud financiera controles de criterios 5/6

Información clave

Actualizaciones recientes sobre salud financiera

We're Not Worried About Research Solutions' (NASDAQ:RSSS) Cash Burn

Companies Like Research Solutions (NASDAQ:RSSS) Can Afford To Invest In Growth

Recent updates

Third quarter 2024 earnings released: EPS: US$0.003 (vs US$0.009 in 3Q 2023)

Research Solutions, Inc. to Report Q3, 2024 Results on May 09, 2024

Insider recently sold US$199k worth of stock

Take Care Before Diving Into The Deep End On Research Solutions, Inc. (NASDAQ:RSSS)

Artko Capital - Research Solutions: A Tumultuous Year But Outlook And Growth Look Excellent

Research Solutions Launches AI Platform to Automatically Create Technology Landscape Reports

New minor risk - Profitability

Now 22% undervalued

Second quarter 2024 earnings released: US$0.002 loss per share (vs US$0.01 loss in 2Q 2023)

Research Solutions, Inc. to Report Q2, 2024 Results on Feb 08, 2024

Insider recently sold US$56k worth of stock

Insider recently sold US$254k worth of stock

Insider recently sold US$184k worth of stock

Research Solutions, Inc. Approves Election of Kenneth L. Gayron to Board of Directors

Research Solutions, Inc. (NasdaqCM:RSSS) entered into an agreement to acquire Scite, Inc. for $14.8 million.

Research Solutions, Inc. (NasdaqCM:RSSS) entered into an agreement to acquire Scite, Inc. for $14.8 million.

First quarter 2024 earnings released: US$0.037 loss per share (vs US$0.008 profit in 1Q 2023)

Research Solutions, Inc. to Report Q1, 2024 Results on Nov 09, 2023

Research Solutions, Inc., Annual General Meeting, Nov 14, 2023

Research Solutions, Inc. Announces Resignation of Peter Derycz from Board of Directors

Research Solutions, Inc. (NASDAQ:RSSS) Shares Could Be 46% Below Their Intrinsic Value Estimate

Full year 2023 earnings: EPS exceeds analyst expectations

Research Solutions, Inc. to Report Q4, 2023 Results on Sep 14, 2023

Research Solutions, Inc. Announces Resignation of Eugene Robin as a Member of the Board of Directors

Research Solutions, Inc. Provides Earnings Guidance for the Fiscal Fourth Quarter and Full Year Fiscal 2023

Bristol Capital Advisors Discloses its Views on Research Solutions

Research Solutions, Inc. (NasdaqCM:RSSS) acquired Resolute Innovation, Inc.

Third quarter 2023 earnings: EPS exceeds analyst expectations

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Research Solutions, Inc. to Report Q2, 2023 Results on Feb 09, 2023

Independent Director exercised options to buy US$101k worth of stock.

We're Not Worried About Research Solutions' (NASDAQ:RSSS) Cash Burn

First quarter 2023 earnings released: EPS: US$0.008 (vs US$0.014 loss in 1Q 2022)

Forecast to breakeven in 2024

Research Solutions, Inc. to Report Q1, 2023 Results on Nov 10, 2022

Research Solutions Launches Curedatis, a Rapid Literature Review Platform for the Life Sciences Industry

Research Solutions, Inc., Annual General Meeting, Nov 17, 2022

Research Solutions, Inc. (NasdaqCM:RSSS) agreed to acquire Customer Contracts for AutoDoc Service of FIZ Karlsruhe from Fiz Karlsruhe - Leibniz-Institut FÜR Informationsinfrastruktur Gmbh.

Full year 2022 earnings: EPS exceeds analyst expectations

Research Solutions reports Q4 results

Research Solutions, Inc. to Report Q4, 2022 Results on Sep 22, 2022

Companies Like Research Solutions (NASDAQ:RSSS) Can Afford To Invest In Growth

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Research Solutions, Inc. Announces the Appointed of Barbara J. Cooperman to the Board of Directors

Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Research Solutions Launches Automated Scholarly Literature Access Platform for Academic Institutions

First quarter 2022 earnings released: US$0.014 loss per share (vs US$0.001 profit in 1Q 2021)

Full year 2021 earnings released: US$0.011 loss per share (vs US$0.031 loss in FY 2020)

Research Solutions, Inc. Provides Earnings Guidance for the Fiscal Fourth Quarter Ended June 30, 2021

Research Solutions, Inc. Unveils Article Galaxy Version 3.0 - in A Time When Rapid Scientific Research Is Crucial

Chief Technology Officer recently sold US$89k worth of stock

Independent Director has left the company

Independent Director exercised options to buy US$151k worth of stock.

New 90-day low: US$2.14

Second quarter 2021 earnings released: US$0.01 loss per share (vs US$0.028 loss in 2Q 2020)

The Research Solutions (NASDAQ:RSSS) Share Price Is Up 402% And Shareholders Are Delighted

Research Solutions, Inc. to Report Q2, 2021 Results on Feb 11, 2021

New 90-day high: US$2.46

Our View On Research Solutions' (NASDAQ:RSSS) CEO Pay

First quarter 2021 earnings released: EPS US$0.001

Research Solutions, Inc. to Report Q1, 2021 Results on Nov 12, 2020

New 90-day low: US$2.23

Research Solutions Partners with BIO Business Solutions to Bring One-Click Scientific Literature Access to the Biotech Industry

Full year earnings released - US$0.031 loss per share

Research Solutions, Inc. to Report Q4, 2020 Results on Sep 24, 2020

New 90-day low: US$2.29

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Análisis de cash runway

Descubre empresas con salud financiera